Sale!

NLRP1 Gene Corneal intraepithelial dyskeratosis and ectodermal dysplasia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the NLRP1 gene, which are linked to corneal intraepithelial dyskeratosis and ectodermal dysplasia. These conditions are part of a group of disorders that affect the skin, hair, nails, and occasionally the teeth and sweat glands, often leading to symptoms from birth or early childhood. Corneal intraepithelial dyskeratosis specifically impacts the eyes, leading to vision problems due to abnormal growth of the cornea.

The test, priced at 4400 AED, utilizes advanced genetic sequencing techniques to analyze the NLRP1 gene, aiming to provide accurate diagnosis and insights. This information is crucial for understanding the risk of passing the condition to offspring, planning treatments, and managing symptoms effectively. Conducted at DNA Labs UAE, a facility known for its state-of-the-art technology and expertise in genetic diagnostics, this test represents a significant step forward in personalized medicine and genetic understanding of complex dermatological and ocular conditions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia Genetic Test

Are you concerned about corneal intraepithelial dyskeratosis and ectodermal dysplasia? DNA Labs UAE offers a comprehensive genetic test to detect mutations in the NLRP1 gene that may be responsible for these conditions.

Test Details

The NLRP1 gene is associated with various genetic disorders, including corneal intraepithelial dyskeratosis and ectodermal dysplasia. Our NGS genetic testing method allows us to sequence the entire coding region of the NLRP1 gene, enabling us to identify any mutations that may be present.

Corneal intraepithelial dyskeratosis is a rare inherited disorder that affects the outer layer of the cornea, leading to vision impairment and eye irritation. Ectodermal dysplasia, on the other hand, is a group of inherited disorders that affect the development of skin, hair, nails, teeth, and sweat glands.

By undergoing our NLRP1 gene test, you can obtain a diagnosis for these genetic disorders and gain valuable information about the inheritance pattern of the condition. This information can be particularly useful for family planning and genetic counseling.

Test Components and Price

Our NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia Genetic Test is priced at AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery

Once the sample is received, our laboratory will process the test and deliver the report within 3 to 4 weeks.

Test Type and Doctor

The NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia Genetic Test falls under the category of Ophthalmology Disorders. It is recommended to consult an Ophthalmologist for this test.

Test Department

The NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia Genetic Test is conducted in our Genetics department.

Pre-Test Information

Before undergoing the NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia Genetic Test, it is essential to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia.

Treatment and Management

Treatment for corneal intraepithelial dyskeratosis and ectodermal dysplasia primarily focuses on managing symptoms and improving the quality of life. This may involve the use of eye drops or surgery for corneal problems, as well as dental prosthetics or hair replacement therapy for ectodermal dysplasia.

Don’t let genetic disorders affect your life. Get tested today with DNA Labs UAE’s NLRP1 Gene Corneal Intraepithelial Dyskeratosis and Ectodermal Dysplasia Genetic Test!

Test Name NLRP1 Gene Corneal intraepithelial dyskeratosis and ectodermal dysplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NLRP1 Gene Corneal intraepithelial dyskeratosis and ectodermal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NLRP1 Gene Corneal intraepithelial dyskeratosis and ectodermal dysplasia NGS Genetic DNA Test gene NLRP1
Test Details

The NLRP1 gene is associated with various genetic disorders, including corneal intraepithelial dyskeratosis and ectodermal dysplasia. NGS genetic testing can be used to identify mutations in this gene that may be responsible for these conditions.

Corneal intraepithelial dyskeratosis is a rare inherited disorder that affects the outer layer of the cornea, leading to vision impairment and eye irritation. Ectodermal dysplasia is a group of inherited disorders that affect the development of skin, hair, nails, teeth, and sweat glands.

NGS genetic testing involves sequencing the entire coding region of the NLRP1 gene to identify any mutations that may be present. This test can help diagnose these genetic disorders and provide information on the inheritance pattern of the condition, which can be useful for family planning and genetic counseling.

Treatment for corneal intraepithelial dyskeratosis and ectodermal dysplasia is typically focused on managing symptoms and improving quality of life. This may include eye drops or surgery for corneal problems, and dental prosthetics or hair replacement therapy for ectodermal dysplasia.